Name,Color
Nonstop_Mutation,#A6CEE3FF
Frame_Shift_Del,#1F78B4FF
IGR,#B2DF8AFF
Missense_Mutation,#33A02CFF
Silent,#FB9A99FF
Nonsense_Mutation,#a50f15
RNA,#FDBF6FFF
Splice_Site,#FF7F00FF
Intron,#CAB2D6FF
Frame_Shift_Ins,#6A3D9AFF
Nonstop_Mutation,#FFFF99FF
In_Frame_Del,#B15928FF
ITD,#9E0142FF
In_Frame_Ins,#df65b0
Translation_Start_Site,#F46D43FF
Multi_Hit,#000000FF
Amp,#EE82EEFF
Del,#4169E1FF
Complex_Event,#7B7060FF
Promoter,#8DD3C7FF
Fusion,#01665EFF
INS,#2B8CBEFF
INDEL,#6a3d9a
DEL,#C51B8AFF
SNV,#1C9099FF
Chr19_Loss,#542788FF
HLA_LOH,#006D2CFF
Amplification,#E41A1CFF
Deletion,#253494FF
MSI-L,#C994C7FF
MSI-H,#DD1C77FF
WGD,#F03B20FF
C1,#1F77B4FF
C2,#FF7F0EFF
C3,#2CA02CFF
Kataegis,#993404FF
SV,#FF7F00FF
synonymous_variant,#54278FFF
p53_deficiency,#253494FF
RTK-RAS+,#35978FFF
LOH,#374E55FF
Adenocarcinoma,#a6611a
Adenosquamous carcinoma,#f1b6da
Carcinoid,#d01c8b
Carcinoid tumor,#d01c8b
Squamous carcinoma,#fc8d59
AFR,#8da0cb
EAS,#66c2a5
EUR,#fc8d62
AMR or Mixed,#e78ac3
BRCA1_type,#b3de69
BRCA2_type,#fdb462
F,#fb8072
Female,#fb8072
M,#80b1d3
Male,#80b1d3
Forte,#FF7F0EFF
Mezzo-forte,#2CA02CFF
Piano,#1F77B4FF
High,#e31a1c
Low,
Moderate,
MMR_deficient,#fb9a99
MMR_proficient,
Smoker,#1f78b4
Non-Smoker,
Others,
Y,#f0027f
Yes,#f0027f
Kunming,#2ca25f
Xuanwei,#de2d26
0,#f7f7f7
1,#fdbe85
2,#fd8d3c
3,#d94701
C>A,#2EBAED
C>G,#000000
C>T,#DE1C14
T>A,#D4D2D2
T>C,#ADCC54
T>G,#F0D0CE
SNP,#F0D0CE